3F Therapeutics Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 4,300

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $27.6M

3F Therapeutics General Information

Description

Developer, manufacturer, and marketer of cardiovascular devices for patients with unmet clinical needs in the United States. The company's products include Aortic Bioprosthesis, a biological replacement aortic heart valve to maintain flow characteristics after implant. It's products under development includes Invasive and Transapical Aortic heart replacement technology, including Enable Aortic Heart Valve, Entrata Aortic Valve system, and Endurance Valve System to reduce surgical cross-clamp and cardio-pulmonary bypass time, utilization for congestive heart failure in patients with right heart failure symptoms, and to replicate the natural mitral apparatus.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 710 Medtronic Parkway
  • Minneapolis, MN 55432
  • United States
+1 (763)
Primary Industry
Surgical Devices
Acquirer
Vertical(s)
Corporate Office
  • 710 Medtronic Parkway
  • Minneapolis, MN 55432
  • United States
+1 (763)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

3F Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 02-Oct-2006 $27.6M Completed Generating Revenue
5. Later Stage VC (Series E) 21-Apr-2005 Completed Generating Revenue
4. Later Stage VC (Series D) 03-Oct-2003 Completed Generating Revenue
3. Later Stage VC (Series C) Completed
2. Early Stage VC (Series B) Completed
1. Early Stage VC (Series A) Completed
To view 3F Therapeutics’s complete valuation and funding history, request access »

3F Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

3F Therapeutics Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cardiac Science Corporation Minority
Domain Associates Venture Capital Minority
The Bioscience Investment Trust Limited Partner Minority
To view 3F Therapeutics’s complete investors history, request access »

3F Therapeutics FAQs

  • When was 3F Therapeutics founded?

    3F Therapeutics was founded in 1998.

  • Where is 3F Therapeutics headquartered?

    3F Therapeutics is headquartered in Minneapolis, MN.

  • What is the size of 3F Therapeutics?

    3F Therapeutics has 4,300 total employees.

  • What industry is 3F Therapeutics in?

    3F Therapeutics’s primary industry is Surgical Devices.

  • Is 3F Therapeutics a private or public company?

    3F Therapeutics is a Private company.

  • What is the current valuation of 3F Therapeutics?

    The current valuation of 3F Therapeutics is .

  • What is 3F Therapeutics’s current revenue?

    The current revenue for 3F Therapeutics is .

  • How much funding has 3F Therapeutics raised over time?

    3F Therapeutics has raised $20.2M.

  • Who are 3F Therapeutics’s investors?

    Cardiac Science, Domain Associates, and The Bioscience Investment Trust have invested in 3F Therapeutics.

  • When was 3F Therapeutics acquired?

    3F Therapeutics was acquired on 02-Oct-2006.

  • Who acquired 3F Therapeutics?

    3F Therapeutics was acquired by ATS Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process